Published by Kristen Fischer
![](https://static.wixstatic.com/media/3db0aa_a09db5689f8141c987d5bc5879b8341a~mv2.png/v1/fill/w_768,h_512,al_c,q_90,enc_avif,quality_auto/3db0aa_a09db5689f8141c987d5bc5879b8341a~mv2.png)
(Halfdark / Getty Images)
An article in the New England Journal of Medicine is urging the U.S. Food and Drug Administration (FDA) to implement a 2017 law that would allow hearing aids to be sold over the counter (OTC)—a process that has been delayed by the COVID-19 pandemic.1
The article was published after a November 13 memo penned by Senators Chuck Grassley (R-Iowa) and Elizabeth Warren (D-Mass), calling on the agency to prioritize releasing the guidance.2
The law gave the FDA three years to propose regulations that would govern OTC hearing for adults with mild-to-moderate hearing impairment. The rules were not released and the FDA cited interruptions caused by the COVID-19 pandemic....
Read the full article on Very Well Health here.
Comments